256 related articles for article (PubMed ID: 30063263)
1. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [
Kim JH; Cumming P; Son YD; Kim HK; Joo YH; Kim JH
Synapse; 2018 Dec; 72(12):e22064. PubMed ID: 30063263
[TBL] [Abstract][Full Text] [Related]
2. The relationship between excitement symptom severity and extrastriatal dopamine D
Joo YH; Kim JH; Son YD; Kim HK; Shin YJ; Lee SY; Kim JH
Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):529-540. PubMed ID: 28623450
[TBL] [Abstract][Full Text] [Related]
3. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A
Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366
[TBL] [Abstract][Full Text] [Related]
4. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
Vernaleken I; Fellows C; Janouschek H; Bröcheler A; Veselinovic T; Landvogt C; Boy C; Buchholz HG; Spreckelmeyer K; Bartenstein P; Cumming P; Hiemke C; Rösch F; Schäfer W; Wong DF; Gründer G
J Clin Psychopharmacol; 2008 Dec; 28(6):608-17. PubMed ID: 19011428
[TBL] [Abstract][Full Text] [Related]
5. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: An [
Kim JH; Choe YS; Cumming P; Son YD; Kim HK; Joo YH; Kim JH
Synapse; 2019 Nov; 73(11):e22121. PubMed ID: 31206840
[TBL] [Abstract][Full Text] [Related]
6. [
Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO
Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577
[TBL] [Abstract][Full Text] [Related]
7. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
Kegeles LS; Slifstein M; Xu X; Urban N; Thompson JL; Moadel T; Harkavy-Friedman JM; Gil R; Laruelle M; Abi-Dargham A
Biol Psychiatry; 2010 Oct; 68(7):634-41. PubMed ID: 20673873
[TBL] [Abstract][Full Text] [Related]
8. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
[TBL] [Abstract][Full Text] [Related]
9. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.
Zald DH; Woodward ND; Cowan RL; Riccardi P; Ansari MS; Baldwin RM; Cowan RL; Smith CE; Hakyemez H; Li R; Kessler RM
Neuroimage; 2010 May; 51(1):53-62. PubMed ID: 20149883
[TBL] [Abstract][Full Text] [Related]
10. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
[TBL] [Abstract][Full Text] [Related]
11. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
Vernaleken I; Janouschek H; Raptis M; Hellmann S; Veselinovic T; Bröcheler A; Boy C; Cumming P; Hiemke C; Rösch F; Schäfer WM; Gründer G
Int J Neuropsychopharmacol; 2010 Aug; 13(7):951-60. PubMed ID: 20392299
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
[TBL] [Abstract][Full Text] [Related]
14. High long-term test-retest reliability for extrastriatal
Karalija N; Jonassson L; Johansson J; Papenberg G; Salami A; Andersson M; Riklund K; Nyberg L; Boraxbekk CJ
J Cereb Blood Flow Metab; 2020 Sep; 40(9):1859-1868. PubMed ID: 31506011
[TBL] [Abstract][Full Text] [Related]
15. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY
Neuropsychopharmacology; 2005 Dec; 30(12):2283-9. PubMed ID: 16123775
[TBL] [Abstract][Full Text] [Related]
16. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
Riccardi P; Baldwin R; Salomon R; Anderson S; Ansari MS; Li R; Dawant B; Bauernfeind A; Schmidt D; Kessler R
Biol Psychiatry; 2008 Jan; 63(2):241-4. PubMed ID: 17586476
[TBL] [Abstract][Full Text] [Related]
17. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
[TBL] [Abstract][Full Text] [Related]
18. Posterior dopamine D2/3 receptors and brain network functional connectivity.
Nagano-Saito A; Lissemore JI; Gravel P; Leyton M; Carbonell F; Benkelfat C
Synapse; 2017 Nov; 71(11):. PubMed ID: 28700819
[TBL] [Abstract][Full Text] [Related]
19. Nigrostriatal and Mesolimbic D
Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
[TBL] [Abstract][Full Text] [Related]
20. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
